For how we live.
A meta-analysis of consumer neurofeedback found no benefit for cognition, mindfulness or physical health and only a small effect on distress — even though the headbands do record real brain activity.
In 62 adults scanned under psilocybin during rest, meditation, music, and film, brain networks reorganized differently by setting — and more reorganization tracked with more positive experiences.
University of Florida researchers identify excess glycan production as a driver of Alzheimer's pathology, and find oral glucosamine worsened cognition in mice and tracked with faster decline.
The same drug sold as Zepbound and Mounjaro reduced cocaine-evoked dopamine release and blocked drug-associated place preference in rodents. It's animal data, not a human addiction treatment.
Researchers profiled nearly 356,000 nuclei from post-mortem hippocampi across five groups. Chromatin accessibility in neurogenic cells was already altered in people with preclinical Alzheimer's pathology.